COVID-19 COAGCARE: HAND-HELD, POINT OF CARE THROMBOELASTOGRAPHY BLOOD DIAGNOSTIC PLATFORM TO SCREEN FOR COVID-19 ASSOCIATED COAGULOPATHY

$2,860,194FY2021Defense Health AgencyDOD

Abram Scientific, Inc., Menlo Park

Investigators